【作者单位】1 Department of Biochemistry and Molecular Biology, Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan University School of Basic Medical Sciences, 185 Donghu Road, Bldg. 2, 2-209, Wuhan 430071, China 2 Medical College, Tibet University, Lhasa 850000, China 3 Department of Pharmacy, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
【摘要】 Isoliquiritigenin (ISL) exhibits antioxidation and anti-inflammation activity. We sought to investigate the effects and mechanism of ISL on the development of atherosclerotic lesions in apolipoprotein E-deficient (apoE -/- ) mice. Firstly, we determi...
